Mineralocorticoid receptor antagonists and prevention of atrial fibrillation in patients with hypertension

Kardiol Pol. 2020 Jun 25;78(6):609-610. doi: 10.33963/KP.15452. Epub 2020 Jun 25.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Atrial Fibrillation*
  • Humans
  • Hypertension*
  • Mineralocorticoid Receptor Antagonists
  • Risk Factors
  • Secondary Prevention

Substances

  • Mineralocorticoid Receptor Antagonists